Clinical Edge Journal Scan

CRC: Severe inflammatory response in early postoperative period increases risk for recurrence


 

Key clinical point: An early severe postoperative inflammatory response increased the risk for recurrence in patients with colorectal cancer (CRC) who underwent curative surgery, with the recurrence hazard being early and persistently higher in patients with high vs low C-reactive protein (CRP) levels.

Major finding: High vs low CRP levels was a significant predictor of worse 5-year RFS (adjusted hazard ratio 2.21; P < .001) with the hazard function peak being higher and earlier in the high ( peak rate 0.0142; peak months 5.6) vs low (peak rate 0.0073; peak months 8.4) CRP group.

Study details: The data come from a retrospective study including 422 patients with stage I-IV CRC who underwent curative surgery and were followed for 5 years after surgery.

Disclosures: This study did not report the source of funding. No conflicts of interest were declared.

Source: Nakamura Y et al. Impact of severe postoperative inflammatory response on recurrence after curative resection of colorectal cancer. Int J Colorectal Dis. 2022;37(11):2375-2386 (Oct 24). Doi: 10.1007/s00384-022-04271-y

Recommended Reading

Link between PCOS and increased risk of pancreatic cancer?
MDedge Hematology and Oncology
Chronic hepatitis B infections associated with a range of liver malignancies
MDedge Hematology and Oncology
Third COVID booster benefits cancer patients
MDedge Hematology and Oncology
Chronic stress, especially race related, may hasten cancer death
MDedge Hematology and Oncology
How AI is, or will soon be, relevant in radiation oncology
MDedge Hematology and Oncology
Colonoscopy screening leads to modest reduction in risk for CRC
MDedge Hematology and Oncology
Effect of early treatment and oxaliplatin discontinuation in patients with stage III colon cancer
MDedge Hematology and Oncology
Metastatic microsatellite-stable CRC: CXD101 and nivolumab combo shows promise in phase 2
MDedge Hematology and Oncology
Impact of synchronous ovarian metastases on 3-year overall survival in CRC
MDedge Hematology and Oncology
High risk for incident cardiovascular disease in patients with high-risk stage II-III CRC
MDedge Hematology and Oncology